Eleven Chinese healthcare and biotechnology companies filed applications to list on the Hong Kong stock exchange in the last two days of September, taking advantage of an ongoing investment boom in the sector.
Advertisement
The best-known names a
Continue Reading on South China Morning Post
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.